This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q25 (Congenital malformations of great arteries) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date) |
| B. Synonyms | Patent ductus arteriosus (PDA), coarctation of the aorta (CoA), interrupted aortic arch (IAA), pulmonary artery stenosis (peripheral type), pulmonary atresia (Q25.5) |
| C. Adult onset | Mild coarctation of the aorta and small PDA are often asymptomatic into adulthood and commonly found incidentally through hypertension or a heart murmur. |
| 1. History | Harvey described the ductus arteriosus in 1628; Gross performed the first surgical PDA ligation in 1944; Crafoord performed the first resection and anastomosis for coarctation of the aorta in 1945 |
| 2. Causes | PDA: abnormal postnatal ductal constriction mechanism; CoA: abnormal aortic arch development and ductal tissue migration theory |
| 3. Genetics | Turner syndrome 45,X (CoA), 22q11.2 deletion (interrupted aortic arch), TFAP2B and MYH11 (familial PDA) |
| 4. General epidemiology | PDA 0.05–0.1% of term infants, up to 60% of preterm infants; CoA 0.3–0.4/1,000 live births; IAA 0.015/1,000 |
| 5. Pathophysiology | PDA: abnormal oxygen-sensitive K+ channel and prostaglandin mechanisms; CoA: theory of migration and adhesion of contractile ductal tissue into the aorta |
| 6. Symptoms | Large PDA: infant heart failure and pulmonary hypertension; CoA: upper limb hypertension, headache, lower limb claudication; IAA: neonatal shock |
| 7. Signs | PDA: continuous machinery murmur, wide pulse pressure; CoA: upper–lower limb blood pressure difference, weak femoral pulses, rib notching |
| 8. Screening | Neonatal pulse oximetry (upper–lower limb difference), four-limb blood pressure, auscultation, chest X-ray |
| 9. Diagnosis | Echocardiography, CT/MR angiography (CoA, IAA), cardiac catheterization (pressure measurement, intervention planning) |
| 10. Treatment | PDA: indomethacin/ibuprofen (preterm infants), percutaneous device closure, surgical ligation; CoA: balloon angioplasty/stent or surgical repair |
| 11. Prognosis | Excellent prognosis after PDA closure; after CoA repair, risks of residual hypertension, restenosis, and aortic complications persist |
| 12. Prevention | Prevention of preterm birth (reducing PDA risk), prenatal diagnosis, cardiovascular screening in Turner syndrome, lifelong follow-up after CoA repair |
| 13. References | Congenital aortic stenosis and coarctation: current understanding and management … and 9 other papers |
Historically, the most important congenital malformations of the great arteries are patent ductus arteriosus (PDA) and coarctation of the aorta (CoA). The ductus arteriosus, a vascular connection that bypasses the lungs in the fetus, was first described by William Harvey in De Motu Cordis in 1628, and its functional significance was gradually understood over the 19th century. In 1907 Munro theoretically proposed surgical ligation of PDA but did not carry it out, and in 1938 Robert Gross and John Hubbard successfully performed surgical ligation of a PDA in a 7-year-old girl at Boston Children's Hospital, marking the beginning of the history of congenital heart surgery.
The history of coarctation of the aorta began in 1760 when Johann Friedrich Meckel first described a narrowed aorta at autopsy, and in 1903 the first antemortem diagnosis was made by radiological examination. In 1945, Clarence Crafoord and Georg Nylin in Sweden, and Gross in the United States in the same year, each independently succeeded in resection and end-to-end anastomosis of coarctation of the aorta, opening the era of surgical correction. Various surgical modifications were later developed, including subclavian flap aortoplasty (1966), patch aortoplasty, and interposition grafts. The introduction of percutaneous balloon aortoplasty (BAP) in 1982 and stent implantation from the 1990s onward became established as treatments for adults and patients with restenosis.
For congenital malformations of the pulmonary arteries, Potts et al. developed a systemic-to-pulmonary shunt for tetralogy of Fallot in 1954, enabling palliative treatment of patients with pulmonary atresia. Percutaneous balloon angioplasty for peripheral pulmonary artery stenosis was introduced in the 1980s, and intravascular stent implantation was later added, improving the precision and effectiveness of treatment. Since the 2000s, advances in transcatheter pulmonary valve implantation (TPVI) have provided a new option for treating residual stenosis and regurgitation after surgery for pulmonary artery malformations.
The cause of patent ductus arteriosus (PDA) is failure of the physiological closure mechanism of the ductus arteriosus after birth. In the fetus, the ductus arteriosus is kept dilated by prostaglandins (PGE2, PGI2); after birth, as pulmonary respiration raises the oxygen partial pressure and prostaglandins decrease, the ductal smooth muscle contracts, achieving functional closure (12–24 hours after birth). Fibrosis (anatomical closure) is then completed over several days. In term infants, the causes of failure of this process are reduced oxygen sensitivity of the ductal tissue and prostaglandin excess; in preterm infants, PDA prevalence is very high, and the lower the gestational age, the higher the incidence (70–80% in preterm infants under 28 weeks). Rubella virus infection (early pregnancy) is the representative known environmental cause of PDA.
There are two main theories about the cause of coarctation of the aorta (CoA). The ductal tissue theory holds that ductal tissue (contractile vascular tissue) migrates into the aortic isthmus, causing stenosis together with ductal constriction after birth. The flow theory explains that reduced fetal blood flow through the left ventricle and aortic arch leads to underdevelopment of the aortic isthmus. Interrupted aortic arch (IAA) is the most severe form, in which part of the aortic arch fails to develop completely, so continuity between the ascending and descending aorta is lost. Most cases are accompanied by ventricular septal defect and patent ductus arteriosus, and ductus-dependent systemic circulation develops immediately after birth.
The genetics of congenital great artery malformations are dominated by multifactorial causes, but some genetic factors have been identified. Turner syndrome (45,X) is the single chromosomal abnormality most strongly associated with coarctation of the aorta, with CoA present in about 10–20% of women with Turner syndrome. For this association, there is a hypothesis that haploinsufficiency of the SHOX gene on the X chromosome affects vascular development. 22q11.2 deletion syndrome is strongly associated with interrupted aortic arch (type B: interruption between the left carotid and left subclavian arteries), and 22q11.2 deletion is found in more than 50% of patients with IAA.
As a causative gene of familial PDA, TFAP2B (transcription factor AP-2 beta, regulating neural crest cell differentiation) was identified in autosomal dominant familial PDA. In addition, variants in MYH11 (smooth muscle myosin heavy chain) and ACTA2 (vascular smooth muscle actin) have been reported as causes of familial PDA and aortic malformations. These gene variants are understood to directly affect the contractile capacity of ductal smooth muscle. Peripheral pulmonary artery stenosis appears as a major cardiovascular phenotype in Williams syndrome (7q11.23 deletion, ELN haploinsufficiency) and Alagille syndrome (JAG1 variants).
Patent ductus arteriosus (PDA) has an incidence of about 0.5–1 per 1,000 term births, and in preterm infants prevalence rises sharply in inverse proportion to gestational age (about 70–80% in preterm infants under 28 weeks, about 30–60% under 32 weeks). When rubella infection was prevalent, PDA was a major complication of maternal rubella, but it is now rare owing to widespread rubella vaccination. It is about twice as frequent in females.
Coarctation of the aorta (CoA) has an incidence of about 0.3–0.4 per 1,000 live births, accounting for about 5–8% of congenital heart disease, and is about 1.5–2 times more common in boys. Women with Turner syndrome show a prevalence 10–20 times higher than the general population. Interrupted aortic arch (IAA) is a rare malformation at about 0.15–0.2 per 10,000 live births; it almost never occurs in isolation and is mostly accompanied by VSD and patent ductus arteriosus. Pulmonary atresia (Q25.5) occurs in about 0.5–1 per 10,000 live births, and its hemodynamics and treatment differ greatly depending on whether a ventricular septal defect is present.
Physiological closure of the PDA occurs through a mechanism in which the rise in oxygen partial pressure at birth inhibits oxygen-sensitive potassium channels (KV channels) in ductal smooth muscle and raises intracellular calcium concentration, inducing smooth muscle contraction. At the same time, the sharp fall in prostaglandin (PGE2, PGI2) concentrations after birth also contributes to constriction. In preterm infants, ductal smooth muscle is immature, with low oxygen sensitivity and high prostaglandin concentrations, so PDA prevalence is high. PDA in term infants may be caused by structural abnormalities of the ductal smooth muscle itself (deficient muscle layer, abnormal elastic fibers).
According to the ductal tissue migration theory of coarctation of the aorta, contractile smooth muscle cells contained in ductal tissue migrate into the adjacent aortic isthmus with ductal closure at birth, causing stenosis. When this migration extends into the aortic lumen, it forms a characteristic shelf-like posterior ledge. The flow barrier at the stenosis causes hypertension in the ascending aorta and upper limbs, and hypotension and development of collateral circulation distal to the stenosis. In interrupted aortic arch, part of the aortic arch fails to develop completely so continuity is lost, and the entire systemic circulation then depends on right ventricular flow through the ductus arteriosus (ductal-dependent circulation).
Clinical symptoms of PDA depend on the size of the ductus and the shunt volume. A small PDA is asymptomatic, with only a murmur heard. In a moderate or larger PDA, pulmonary overcirculation and left ventricular volume overload from the left-to-right shunt cause congestive heart failure symptoms in infancy, such as feeding difficulty, poor weight gain, tachypnea, and recurrent respiratory infections. If left uncorrected long term, pulmonary hypertension progresses, and upon transition to Eisenmenger syndrome, reversed shunting characteristically produces lower-body cyanosis (differential cyanosis: right hand normal, feet cyanotic).
Symptoms of coarctation of the aorta vary with the severity of the stenosis and age. Severe neonatal CoA presents with rapid circulatory failure and metabolic acidosis as the ductus closes. Mild to moderate adult CoA is characterized by upper limb hypertension, headache, epistaxis, cold lower limbs, and claudication. In refractory hypertension, especially when it occurs in young adults or children, CoA must be ruled out. If left uncorrected long term, the risks of intracranial aneurysm rupture (associated with circle of Willis aneurysms), infective endocarditis, and aortic dissection increase. Interrupted aortic arch is a serious emergency presenting with rapid shock and multiple organ failure as the ductus closes in the neonatal period.
The most characteristic auscultatory finding of PDA is a continuous machinery murmur heard at the upper left sternal border (2nd intercostal space), which begins in systole, envelops the second heart sound, and continues into diastole. With a large shunt volume, the pulse pressure widens and a prominent bounding pulse is palpable. On transition to Eisenmenger syndrome, the murmur disappears and lower-body cyanosis appears.
In coarctation of the aorta, the blood pressure difference between the right upper limb and the lower limbs (normal threshold >20 mmHg) is the most important physical sign, and left upper limb blood pressure depends on whether the origin of the left subclavian artery is distal or proximal to the stenosis. Reduced or delayed femoral pulses (radio-femoral delay) are characteristic. On chest X-ray, a double contour around the coarctation site (double aortic knuckle sign) and rib notching of the inferior margins of the 3rd and lower ribs due to collateral circulation are pathological findings of adult CoA. ECG shows accompanying left ventricular hypertrophy.
In screening for congenital great artery malformations, neonatal pulse oximetry is key for early detection of cyanotic malformations (pulmonary atresia, severe CoA, etc.). In particular, measuring simultaneously at the right wrist (preductal flow) and a lower limb (postductal flow), a difference of 3% or more strongly suggests an aortic arch abnormality or CoA. Four-limb blood pressure measurement (both upper and lower limbs) is an important tool for CoA screening and must be performed in adults with hypertension of unknown cause as well.
Murmur auscultation is the primary tool for PDA screening, and in preterm infants clinical indicators of PDA complications, such as increasing respiratory support requirements, metabolic acidosis, and unstable pulse oximetry, are continuously monitored. On chest X-ray, cardiomegaly (left ventricular dilation) and increased pulmonary vascularity suggest a significant PDA shunt. Evaluating aortic arch morphology and flow on prenatal fetal echocardiography for early detection of CoA and IAA is key to improving neonatal outcomes.
Echocardiography is the primary tool for diagnosing PDA and CoA. Echocardiography for PDA evaluates the location, size, and shunt direction of the ductus, estimated shunt volume (Doppler), presence of pulmonary hypertension, and left ventricular dilation. In CoA, the pressure gradient is estimated by Doppler velocity measurement at the stenosis, and the entire aortic arch and descending aorta are evaluated. In children, the transthoracic window is good, so echocardiography alone is often sufficient for diagnosis, but in adults the window is limited and supplementary imaging is needed.
CT angiography (CTA) and MR angiography (MRA) are essential for evaluating overall aortic arch morphology, the length and shape of the stenosis, collateral vessel development, and the anatomical classification of IAA. MRA allows simultaneous flow and morphological assessment without radiation exposure and is preferred in children and for repeated follow-up. Cardiac catheterization is used for planning percutaneous balloon angioplasty or stent implantation, measuring pulmonary vascular resistance, and precisely defining the anatomy of pulmonary artery malformations.
Pharmacological closure of PDA is achieved mainly by inhibiting prostaglandin synthesis with COX inhibitors (indomethacin, ibuprofen) and is used as first-line treatment for PDA in preterm infants. In term infants or older children and adults, PDA responds poorly to drugs, so transcatheter device closure is the standard treatment, performed using devices such as the Amplatzer Duct Occluder. Surgical ligation is used when percutaneous procedures are difficult or for very large PDAs. In preterm infants with contraindications to indomethacin (renal failure, necrotizing enterocolitis, etc.), acetaminophen is being studied as an alternative.
For coarctation of the aorta, surgical resection and end-to-end anastomosis is the standard in children, while in adult CoA or restenosis percutaneous balloon angioplasty or stent implantation is preferred. Stent implantation has been shown to lower restenosis rates and improve long-term outcomes. In interrupted aortic arch, after maintaining the ductus with urgent prostaglandin E1 administration, early complete surgical correction (VSD closure + aortic arch reconstruction) is the standard. Peripheral pulmonary artery stenosis is treated with percutaneous balloon angioplasty or stent implantation, and surgical correction is needed when the response is insufficient.
Appropriately corrected PDA has an excellent prognosis, and normal life expectancy can be expected with correction in infancy. When an uncorrected large PDA progresses to Eisenmenger syndrome, the prognosis is poor even with pulmonary arterial hypertension–targeted therapy. Even after repair of coarctation of the aorta, the risks of residual hypertension (persisting in about 30–50%), restenosis, aortic aneurysm, and intracranial aneurysm persist in long-term follow-up, so lifelong follow-up by a cardiologist is needed. There is evidence that the younger the age at repair, the lower the risk of residual hypertension and cardiovascular events.
The 30-day mortality after surgical correction of interrupted aortic arch is currently 5–10% at major centers, but in long-term follow-up reoperation is often needed for recurrent left ventricular outflow tract obstruction, aortic restenosis, residual VSD, and others. Pulmonary atresia (with ventricular septal defect) is divided into patients in whom biventricular repair is possible through staged surgery and those in whom it is not, and long-term survival is significantly higher when biventricular repair is possible. Overall, for Q25 group malformations, early diagnosis and treatment at a specialized center are the most important factors determining prognosis.
The most effective strategy for preventing PDA is prevention of preterm birth. Administering corticosteroids at 24–34 weeks of gestation to mothers at high risk of preterm birth accelerates lung maturation and reduces the risk of PDA in preterm infants. Rubella vaccination can almost completely prevent rubella-related PDA. Taking nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy can cause premature constriction of the fetal ductus arteriosus, so avoidance after 20 weeks of gestation is recommended.
Prenatal diagnosis of coarctation of the aorta and great artery malformations is key to early intervention and improved outcomes. In patients diagnosed with Turner syndrome, cardiovascular examination is performed immediately at diagnosis, followed by regular aortic imaging follow-up. In patients after CoA repair, the keys to secondary prevention are hypertension control (target blood pressure <130/80 mmHg), surveillance for restenosis and aortic aneurysm with regular CT/MR angiography, and prevention of infective endocarditis. Because intracranial aneurysms have a high incidence in congenital heart malformations with CoA, cranial MR angiography should be performed when symptoms (headache, visual changes) occur.
Gross RE, Hubbard JP. Surgical ligation of a patent ductus arteriosus: report of first successful case. JAMA. 1939;112(8):729–731. DOI: 10.1001/jama.1939.02800080049012.
Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease. Journal of the American College of Cardiology. 2019;73(12):e81–e192. DOI: 10.1016/j.jacc.2018.08.1029. PMID: 30121239.
Krichenko A, Benson LN, Burrows P, et al. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. American Journal of Cardiology. 1989;63(12):877–880. DOI: 10.1016/0002-9149(89)90064-7. PMID: 2929407.
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. European Heart Journal. 2021;42(6):563–645. DOI: 10.1093/eurheartj/ehaa554. PMID: 32860028.
Rosenthal E. Coarctation of the aorta from fetus to adult: curable condition or life long disease process? Heart. 2005;91(11):1495–1502. DOI: 10.1136/hrt.2004.057182. PMID: 16230453.
Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease. Circulation. 2009;120(5):447–458. DOI: 10.1161/CIRCULATIONAHA.109.192576. PMID: 19581492.
Driscoll DJ. Pathophysiology of structural congenital heart disease. Circulation. 2007;115(25):3352–3360. DOI: 10.1161/CIRCULATIONAHA.107.702878. PMID: 17592088.
Zeltser I, Menteer J, Gaynor JW, et al. Impact of re-coarctation following the Norwood operation on survival in the balloon angioplasty era. Journal of the American College of Cardiology. 2005;45(12):2061–2066. DOI: 10.1016/j.jacc.2004.12.073. PMID: 15963411.
Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany. Klinische Pädiatrie. 2010;222(5):321–326. DOI: 10.1055/s-0030-1254155. PMID: 20799151.
Van Mierop LH, Kutsche LM. Interruption of the aortic arch and coarctation of the aorta: pathogenetic relations. American Journal of Cardiology. 1984;54(7):829–834. DOI: 10.1016/s0002-9149(84)80211-4. PMID: 6486066.